‘Jeopardy!’ Update: Mayim Bialik and Ken Jennings Will Continue to Split Hosting Duties Through July

Tony Maglio
·2 min read

Mayim Bialik and Ken Jennings will continue to split “Jeopardy!” hosting duties through the end of Season 38, which will take the Sony quiz show through July. Michael Davies will remain executive producer.

“We are delighted to let you know that Mayim Bialik and Ken Jennings will continue to share hosting duties through the end of ‘Jeopardy!’ Season 38, and Michael Davies will remain as executive producer,” a Sony spokesperson told TheWrap. “We’re so pleased to have such an excellent and experienced team in front of and behind the camera as we head into 2022!”

New episodes are scheduled to air until July 29, 2022 — COVID permitting, of course.

Bialik’s “Jeopardy!” spinoff duties just got a debut date last week.

Executive produced by Davies and produced by “Jeopardy!” studio Sony Pictures Television, the “Call Me Kat” star’s “Jeopardy! National College Championship” will kick off Tuesday, Feb. 8 at 8/7c on ABC. The nine-episode, 14-day event will feature 36 students from 36 colleges and universities from across the country.

Bialik has recently been splitting temporary hosting duties on “Jeopardy!” with Ken Jennings while the game show searches for a full-time replacement for the late Alex Trebek, following the quick ousting of Mike Richards — the syndicated series’ first choice after a rotating stable of guest hosts (including Bialik and Jennings) tried out for the role.

The “Jeopardy! National College Championship” tournament marks Bialik’s first turn at the job she was initially hired to do in August, which is permanent host of “Jeopardy!” specials and spinoffs. Bialik was given that position at the same time as Richards was named the new permanent host of the OG “Jeopardy!,” but he exited just over a week later, one day after the show returned to production for its 38th season.

His departure followed the resurfacing of a gender discrimination lawsuit from his time with “The Price is Right” and multiple misogynistic comments he made on a podcast he co-hosted in the last decade.

Trebek died in November 2020 after a very public battle with pancreatic cancer. He was 80.

  • Up next
  • Up next
  • Up next
  • Up next

Latest Stories

  • Alfa Laval AB's Dividend Analysis

    Alfa Laval AB (ALFVY) recently announced a dividend of $0.71 per share, payable on 2024-05-20, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Alfa Laval AB's dividend performance and assess its sustainability.

  • Supercar maker McLaren hit by £375m impairment charge

    McLaren Group, the British supercar maker and Formula One team-backer, has given lenders signs of an improvement in its financial performance even after a £375m impairment charge propelled it to a record loss last year. Sky News has learnt that McLaren has told bondholders that it made losses of £873m in the 12 months ending December 31. The Woking-based company's financial travails reflected an ongoing financial restructuring that was completed earlier this year.

  • Celanese Corp's Dividend Analysis

    Celanese Corp(NYSE:CE) recently announced a dividend of $0.7 per share, payable on 2024-05-13, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Celanese Corps dividend performance and assess its sustainability.

  • Q1 2024 Quantumscape Corp Earnings Call

    Q1 2024 Quantumscape Corp Earnings Call

  • Senate Passes $95 Billion Foreign Aid Package

    On April 23, the U.S. Senate voted 79-18 to approve foreign aid for Ukraine, Israel and Taiwan, 'The Guardian' reports. "Today the Senate sends a unified message to the entire world: America will always defend democracy in its hour of need.", Senate Majority Leader Chuck Schumer, via statement.

  • Comcast tops revenue estimates on streaming growth, strong park attendance

    Peacock added 3 million subscribers in the first quarter, taking its total to 34 million and outpacing estimates of 2.32 million by Visible Alpha, thanks to higher investments that Comcast hopes will help it compete better with Netflix and Disney+. Peacock became the first streaming service to exclusively air an NFL playoff game in January, which was one of its biggest growth drivers in the quarter.

  • UCB SA's Dividend Analysis

    UCB SA (UCBJY) recently announced a dividend of $0.73 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into UCB SA's dividend performance and assess its sustainability.

  • Sampo Oyj's Dividend Analysis

    Sampo Oyj (SAXPY) recently announced a dividend of $0.97 per share, payable on 2024-05-22, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Sampo Oyj's dividend performance and assess its sustainability.

  • UPDATE 1-Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda

    Merck & Co on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda. The New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous forecast of $8.44 to $8.59, and sales of $63.1-$64.3 billion for the year. Merck's new forecast includes a $0.26 per share charge for its $680 million acquisition of cancer drug developer Harpoon Therapeutics, which closed in the first quarter of 2024, the company said.

  • Nasdaq's revenue beats on strong demand for fintech products

    Revenue from its financial technology unit surged 71% to $392 million in the first quarter, while revenue from its index business jumped 53% to $168 million. Nasdaq, like its peers, has been on an acquisition spree to diversify its portfolio of technology and intellectual property after regulations in 2005 opened the equities trading market up to competition from brokers. Net revenue in the first quarter jumped 22% to $1.12 billion.

  • Q1 2024 Moelis & Co Earnings Call

    Q1 2024 Moelis & Co Earnings Call

  • Basf SE's Dividend Analysis

    Basf SE(BASFY) recently announced a dividend of $0.92 per share, payable on 2024-05-10, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Basf SE's dividend performance and assess its sustainability.

  • Why Race Across The World couldn’t go through China

    Why wasn't Race Across The World able to go through China?

  • Bank of Montreal's Dividend Analysis

    Bank of Montreal (NYSE:BMO) recently announced a dividend of $1.51 per share, payable on 2024-05-28, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Bank of Montreal's dividend performance and assess its sustainability.

  • West Pharma posts beat-and-raise quarter aided by strong demand for injectables

    West Pharmaceutical Services on Thursday beat quarterly profit estimates and raised its annual profit forecast, banking on rising demand for cartridges and syringes used to manufacture injectable therapies. The company expects sales growth to ramp up as the year progresses, partly due to a surge in demand for components used in the packaging of newer treatments, including Novo Nordisk's diabetes drug Ozempic, weight-loss drug Wegovy, and Eli Lilly's diabetes drug Mounjaro. CEO Eric Green said that he expects a majority of sales growth to take place in the second half, as biotech clients work through their existing inventory.

  • Petroleo Brasileiro SA Petrobras's Dividend Analysis

    Petroleo Brasileiro SA Petrobras (NYSE:PBR) recently announced a dividend of $0.42 per share, payable on an unconfirmed future date, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Petroleo Brasileiro SA Petrobras's dividend performance and assess its sustainability.

  • Bristol Myers posts quarterly loss, revenue rises 5%

    Bristol Myers Squibb on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio and Mirati Therapeutics offset a 5% increase in revenue. The New Jersey-based drugmaker posted a loss of $4.40 per share, including charges for acquired research and development. On a net basis, Bristol's loss was $5.89 per share.

  • Munchener Ruckversicherungs-Gesellschaft AG's Dividend Analysis

    Munchener Ruckversicherungs-Gesellschaft AG (MURGY) recently announced a dividend of $1.61 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Munchener Ruckversicherungs-Gesellschaft AG's dividend performance and assess its sustainability.

  • Blackstone Inc's Dividend Analysis

    Blackstone Inc (NYSE:BX) recently announced a dividend of $0.83 per share, payable on 2024-05-06, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Blackstone Inc's dividend performance and assess its sustainability.

  • Mama's Creations Inc (MAMA) (Q4 2024) Earnings Call Transcript Highlights: Robust Growth and ...

    Discover how Mama's Creations Inc achieved significant revenue and profit increases, and their strategic moves for future growth.